Research and Clinical Trials, Skin Cancer/Melanoma

Meet the investigator: Roxana S. Dronca, M.D.

By Nicole Ferrara • September 12, 2018
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Roxana S. Dronca, M.D., a hematologist and an oncologist at Mayo Clinic in Jacksonville, Florida, discusses her research on tumor immunology, malignant melanoma and genitourinary malignancies.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer genitourinary immunology malignancies melanoma research Research and Clinical Trials Skin Cancer/Melanoma tumor
Subscribe
Request an Appointment
Find a Clinical Trial
Clinical trials: A significant part of cancer care

Mayo Clinic doctors discuss the role clinical trials — research studies that test new treatments and other interventions — play in cancer care.

Mayo Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer

The presence of a specific genetic mutation — KRAS circulating tumor DNA (ctDNA) — strongly indicates a higher risk of spread and worse survival rates for people with pancreatic cancer.

Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.